Markets & Regulations

© GettyImages/chaluk

Reducing barriers to mainstream gene therapy

By Jane Byrne

AskBio, which develops adeno-associated virus (AAV) gene therapies for genetic disorders, has won an R&D grant valued at £2m (around US$2.7m) from Scottish Enterprise.

Follow us

Products

View more

Webinars